Next webinar

Dec 5, 2024

1 PM (CET)

MS-Teams

scheduled

FOUR

Edition FOUR of our webinar series will zoom in on spectrum 2 and provide more insight into Eleva’s technology.

Stay in the loop

Speakers

To be announced

More information soon

To be announced

More information soon

To be announced

More information soon

Stay in the loop

Subscribe to our next webinars

I consent to the processing of my personal data for the purpose of establishing contact in accordance with Article 6 paragraph 1 lit a of the Basic Data Protection Regulation (DSGVO). In accordance with Article 13 of the Basic Data Protection Regulation (DSGVO), we would like to provide you with comprehensive information about the processing of your personal data. You can read all relevant information in our data protection policy.

Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.

Our webinar series offers firsthand insights from experts, scientists and clinicians about C3 Glomerulopathy (C3G) such as epidemiology, diagnosis, treatment, management and coping strategies. You will hear about all the relevant aspects, including Eleva’s initiatives to develop new treatment options for this ultrarare disease with high unmet medical need. Join the series for regular updates on Eleva’s clinical development efforts.

Stay in the loop

Next webinars

  • Oct 17, 2024

    Webinar Three 
    ...is dedicated to pediatric case reports and Eleva's production of Factor H (CPV-104).

  • Dec 5, 2024

    Webinar Four 
    ...will zoom in on spectrum 2 and provide more insight into Eleva’s technology.
You missed one of our editions?

Previous webinars

  • Webinar Two

    Dr. Andreas Busch / Dr. Fernando Caravaca-Fontán / Prof. Thorsten Wiech

    Jun 13, 2024

    recorded

  • Webinar One

    Dr. Bjoern Cochlovius / Prof. Dr. Peter Zipfel / Prof. Dr. Dinesh Khullar

    Mar 14, 2024

    recorded

Back to

All webinars